Inozyme Pharma Inc. (INZY)
NASDAQ: INZY
· Real-Time Price · USD
4.00
0.00 (0.00%)
At close: Jun 30, 2025, 3:59 PM
Inozyme Pharma Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 25.85M | 21.08M | 24.57M | 15.23M | 20.62M | 34.59M | 46.9M | 40.84M | 49.02M | 32.91M | 44.04M | 62.62M | 31.94M | 23.32M | 27.23M | 26.24M | 16.49M |
Short-Term Investments | 58.93M | 92.01M | 107.03M | 129.29M | 145.53M | 154M | 145.55M | 99.4M | 81.91M | 94.95M | 97.41M | 88.86M | 65.83M | 88.48M | 98.05M | 111.22M | 128.6M |
Long-Term Investments | n/a | n/a | n/a | 311K | 311K | 311K | 311K | 311K | 354K | n/a | 354K | 379K | 354K | 88.48M | 354K | 354K | 2.55M |
Other Long-Term Assets | 509K | 1.16M | 769K | 458K | 311K | 1.69M | 1.7M | 3.86M | 3.81M | 4.16M | 3.81M | 3.81M | 3.81M | -84.72M | 2.07M | 2.08M | 3.3M |
Receivables | n/a | 467K | n/a | n/a | n/a | 385K | n/a | n/a | n/a | 115K | 96K | 106K | 48K | 62K | 73K | 95K | 122K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -106K | n/a | -62K | n/a | n/a | n/a |
Other Current Assets | 8.86M | 311K | 9.33M | 8.44M | 8.17M | n/a | 8.41M | 3.34M | 3.22M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 93.64M | 120.68M | 140.94M | 152.96M | 174.32M | 196.25M | 200.86M | 143.59M | 134.15M | 131.39M | 145.93M | 153.75M | 100.58M | 115.34M | 130.58M | 140.96M | 148.04M |
Property-Plant & Equipment | 1.02M | 1.35M | 1.66M | 1.98M | 2.31M | 2.59M | 2.84M | 3.17M | 3.48M | 3.64M | 3.93M | 4.05M | 4.18M | 4.44M | 4.74M | 4.86M | 5.03M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 1.53M | 2.51M | 2.42M | 2.75M | 2.62M | 4.6M | 4.85M | 7.34M | 7.65M | 7.8M | 8.1M | 8.24M | 8.35M | 8.2M | 7.17M | 7.3M | 10.87M |
Total Assets | 95.16M | 123.18M | 143.36M | 155.71M | 176.94M | 200.85M | 205.7M | 150.93M | 141.8M | 139.19M | 154.02M | 161.99M | 108.93M | 123.54M | 137.75M | 148.26M | 158.91M |
Account Payables | 3.67M | 2.53M | 2.21M | 3.53M | 2.17M | 1.17M | 2.01M | 2.01M | 1.81M | 2.54M | 1.39M | 1.34M | 2.2M | 2.39M | 626K | 796K | 1.71M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.81M | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 25.7M | 14.5M | 4.56M | 959K | n/a | 910K | 886K | 862K | 839K | n/a | 794K | 773K | 752K | n/a | 711K | 691K | 672K |
Other Current Liabilities | n/a | 12.29M | 10.59M | -959K | n/a | 7.86M | -886K | 5.66M | 7.05M | n/a | 7.89M | 6.01M | 7.81M | 6.13M | 4.98M | 3.35M | 2.66M |
Total Current Liabilities | 42.78M | 33.9M | 18.34M | 15.54M | 12.41M | 14.69M | 12.28M | 12.08M | 12.58M | 14.71M | 13.13M | 10.57M | 12.26M | 11.63M | 8.94M | 6.97M | 6.83M |
Long-Term Debt | 20.59M | 31.46M | 42.06M | 45.33M | 45.03M | 44.77M | 32.06M | 31.88M | 24.22M | 4.14M | 4.07M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 46K | 124K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 20.59M | 31.46M | 42.23M | 45.75M | 45.7M | 45.68M | 33.21M | 33.26M | 25.87M | 6.09M | 6.11M | 2.24M | 2.44M | 2.64M | 2.83M | 3.01M | 3.19M |
Total Liabilities | 63.37M | 65.36M | 60.57M | 61.29M | 58.11M | 60.37M | 45.49M | 45.34M | 38.45M | 20.8M | 19.24M | 12.81M | 14.7M | 14.27M | 11.77M | 9.98M | 10.03M |
Total Debt | 46.95M | 46.87M | 46.79M | 46.71M | 46.63M | 46.59M | 34.1M | 34.12M | 26.66M | 6.78M | 6.9M | 3.01M | 3.19M | 3.37M | 3.54M | 3.7M | 3.87M |
Common Stock | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 5K | 4K | 4K | 4K | 4K | 2K | 2K | 2K | 2K | 2K |
Retained Earnings | -415.99M | -387.95M | -360.88M | -336.31M | -309.28M | -285.93M | -264.39M | -247.75M | -232.16M | -214.76M | -196.22M | -179.84M | -164.58M | -147.7M | -128.95M | -114.67M | -102.13M |
Comprehensive Income | -5K | 69K | 186K | -103K | -105K | 41K | -78K | 51K | -36K | -205K | -477K | -397K | -129K | 18K | 3K | 18K | 12K |
Shareholders Equity | 31.8M | 57.83M | 82.79M | 94.42M | 118.84M | 140.48M | 160.21M | 105.59M | 103.38M | 118.39M | 134.78M | 149.18M | 94.23M | 109.27M | 125.97M | 138.27M | 148.89M |
Total Investments | 58.93M | 92.01M | 107.03M | 129.6M | 145.85M | 154.31M | 145.55M | 99.4M | 81.91M | 94.95M | 97.41M | 88.86M | 65.83M | 88.48M | 98.05M | 111.22M | 131.15M |